Seeking first vaccine against Lyme disease, Pfizer and French partner Valneva launch major tri - 1br

The trial will enroll about 6000 volunteers, ages 5 and up, at as many as 50 worldwide sites where Lyme disease is a problem, including the U.S..<br /><br />VIEW MORE : https://bit.ly/1breakingnews<br />